Valuation: PERRIGO

Market Cap 1.81B 0 1.56B 1.47B 1.34B 2.51B 173B 2.55B 17.21B 6.73B 86.65B 6.79B 6.65B 288B P/E 2026 *
1,304x
P/E 2027 * 10.9x
Enterprise Value 4.71B 0 4.07B 3.83B 3.48B 6.54B 451B 6.65B 44.83B 17.53B 226B 17.7B 17.32B 750B EV / Sales 2026 *
1.16x
EV / Sales 2027 * 1.12x
Free-Float
99.6%
Yield 2026 *
8.87%
Yield 2027 * 9.1%
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-1.05%-2.81%+23.07%+35.70% 287B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
Average -1.14%+0.43%+27.15%+42.67% 399.46B
Weighted average by Cap. -1.36%+0.32%+39.09%+61.29%

Financials

2026 *2027 *
Net sales 4.06B 0 3.51B 3.29B 3B 5.63B 388B 5.73B 38.6B 15.09B 194B 15.24B 14.91B 646B 4.09B 0 3.53B 3.32B 3.02B 5.67B 391B 5.77B 38.89B 15.2B 196B 15.35B 15.02B 651B
Net income -224M -0 -194M -182M -165M -311M -21.43B -316M -2.13B -833M -10.73B -841M -823M -35.66B -56.95M -0 -49.19M -46.22M -42.04M -79.03M -5.45B -80.33M -542M -212M -2.73B -214M -209M -9.06B
Net Debt 2.9B 0 2.51B 2.36B 2.14B 4.03B 278B 4.1B 27.62B 10.8B 139B 10.91B 10.67B 462B 2.78B 0 2.4B 2.26B 2.05B 3.86B 266B 3.93B 26.47B 10.35B 133B 10.45B 10.22B 443B
Logo PERRIGO
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-